Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus
We compared the cardiovascular diseases (CVD) and risk factors in patients with stage 3–5 chronic kidney disease (CKD) and those with diabetes mellitus by analyzing the MAGNET study data of residents in northern Taiwan. The reimbursement of lipid-lowering therapy was also examined. Of the 1607 parti...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM)
2017-03-01
|
| Series: | International Journal of Gerontology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1873959817300029 |
| _version_ | 1818272843565105152 |
|---|---|
| author | Ta-Chuan Hung Cheng-Huang Su Yih-Jer Wu Chung-Lieh Hung Hung-I. Yeh Li-Yu Wang |
| author_facet | Ta-Chuan Hung Cheng-Huang Su Yih-Jer Wu Chung-Lieh Hung Hung-I. Yeh Li-Yu Wang |
| author_sort | Ta-Chuan Hung |
| collection | DOAJ |
| description | We compared the cardiovascular diseases (CVD) and risk factors in patients with stage 3–5 chronic kidney disease (CKD) and those with diabetes mellitus by analyzing the MAGNET study data of residents in northern Taiwan. The reimbursement of lipid-lowering therapy was also examined. Of the 1607 participants, 63 (31 men) were found to have eGFR<60 ml/min per 1.73 m2 and were defined as the CKD group. In parallel, 149 (73 men) were found to have diabetes. Compared to the diabetic group, the CKD group was older (61.4 ± 9.0 vs 58.0 ± 8.6 years, p < 0.05). Otherwise, the distribution of CVD, hypertension, and family history of CVD, as well as the levels of serum total cholesterol, LDL-C, were similar. We also found 46.0% of the CKD group can not be reimbursed for lipid-lowering therapy. In conclusion, the findings suggested that, in this population, the cardiovascular risk was similar between the CKD and diabetic subjects. |
| first_indexed | 2024-12-12T21:48:31Z |
| format | Article |
| id | doaj.art-18dd8a0fac714701ba63e8f87eba601f |
| institution | Directory Open Access Journal |
| issn | 1873-9598 |
| language | English |
| last_indexed | 2024-12-12T21:48:31Z |
| publishDate | 2017-03-01 |
| publisher | Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM) |
| record_format | Article |
| series | International Journal of Gerontology |
| spelling | doaj.art-18dd8a0fac714701ba63e8f87eba601f2022-12-22T00:10:51ZengTaiwan Society of Geriatric Emergency and Critical Medicine (TSGECM)International Journal of Gerontology1873-95982017-03-01111515210.1016/j.ijge.2016.08.001Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes MellitusTa-Chuan Hung0Cheng-Huang Su1Yih-Jer Wu2Chung-Lieh Hung3Hung-I. Yeh4Li-Yu Wang5MacKay Memorial Hospital, Taipei, TaiwanMacKay Memorial Hospital, Taipei, TaiwanMacKay Memorial Hospital, Taipei, TaiwanMacKay Memorial Hospital, Taipei, TaiwanMacKay Memorial Hospital, Taipei, TaiwanMackay Medical College, New Taipei City, TaiwanWe compared the cardiovascular diseases (CVD) and risk factors in patients with stage 3–5 chronic kidney disease (CKD) and those with diabetes mellitus by analyzing the MAGNET study data of residents in northern Taiwan. The reimbursement of lipid-lowering therapy was also examined. Of the 1607 participants, 63 (31 men) were found to have eGFR<60 ml/min per 1.73 m2 and were defined as the CKD group. In parallel, 149 (73 men) were found to have diabetes. Compared to the diabetic group, the CKD group was older (61.4 ± 9.0 vs 58.0 ± 8.6 years, p < 0.05). Otherwise, the distribution of CVD, hypertension, and family history of CVD, as well as the levels of serum total cholesterol, LDL-C, were similar. We also found 46.0% of the CKD group can not be reimbursed for lipid-lowering therapy. In conclusion, the findings suggested that, in this population, the cardiovascular risk was similar between the CKD and diabetic subjects.http://www.sciencedirect.com/science/article/pii/S1873959817300029cardiovascular riskCKDdiabeteslipid management |
| spellingShingle | Ta-Chuan Hung Cheng-Huang Su Yih-Jer Wu Chung-Lieh Hung Hung-I. Yeh Li-Yu Wang Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus International Journal of Gerontology cardiovascular risk CKD diabetes lipid management |
| title | Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus |
| title_full | Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus |
| title_fullStr | Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus |
| title_full_unstemmed | Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus |
| title_short | Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus |
| title_sort | cardiovascular risk and lipid management reimbursement between patients with stage 3 5 chronic kidney disease and those with diabetes mellitus |
| topic | cardiovascular risk CKD diabetes lipid management |
| url | http://www.sciencedirect.com/science/article/pii/S1873959817300029 |
| work_keys_str_mv | AT tachuanhung cardiovascularriskandlipidmanagementreimbursementbetweenpatientswithstage35chronickidneydiseaseandthosewithdiabetesmellitus AT chenghuangsu cardiovascularriskandlipidmanagementreimbursementbetweenpatientswithstage35chronickidneydiseaseandthosewithdiabetesmellitus AT yihjerwu cardiovascularriskandlipidmanagementreimbursementbetweenpatientswithstage35chronickidneydiseaseandthosewithdiabetesmellitus AT chungliehhung cardiovascularriskandlipidmanagementreimbursementbetweenpatientswithstage35chronickidneydiseaseandthosewithdiabetesmellitus AT hungiyeh cardiovascularriskandlipidmanagementreimbursementbetweenpatientswithstage35chronickidneydiseaseandthosewithdiabetesmellitus AT liyuwang cardiovascularriskandlipidmanagementreimbursementbetweenpatientswithstage35chronickidneydiseaseandthosewithdiabetesmellitus |